141 related articles for article (PubMed ID: 2579516)
21. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
22. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
24. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
Strauer BE; Bohn I; Hahn B; Kment A; Motz U
J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
[TBL] [Abstract][Full Text] [Related]
25. Effects of prenalterol and its N-homoveratryl derivative in the anaesthetized cat.
Maccarrone C; Malta E; Raper C
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):245-50. PubMed ID: 6621718
[No Abstract] [Full Text] [Related]
26. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
[TBL] [Abstract][Full Text] [Related]
27. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
29. Central and splanchnic hemodynamics in the dog during controlled hypotension with adenosine.
Lagerkranser M; Irestedt L; Sollevi A; Andreen M
Anesthesiology; 1984 Jun; 60(6):547-52. PubMed ID: 6731909
[TBL] [Abstract][Full Text] [Related]
30. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
Sire S; Amlie JP; Simonsen S
Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
[TBL] [Abstract][Full Text] [Related]
31. Intravenous prenalterol in acute and chronic heart failure.
Kirlin PC; Pitt B; Lucchesi BR
Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
[No Abstract] [Full Text] [Related]
32. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
[TBL] [Abstract][Full Text] [Related]
33. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
Wahr DW; Swedberg K; Rabbino M; Hoyle MJ; Curran D; Parmley WW; Chatterjee K
Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
35. Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs.
Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
Clin Exp Pharmacol Physiol; 1983; 10(3):219-27. PubMed ID: 6627738
[TBL] [Abstract][Full Text] [Related]
36. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
[TBL] [Abstract][Full Text] [Related]
37. Effects of prenalterol on central haemodynamics and VA/Q distribution early after open-heart surgery.
Anjou-Lindskog E; Broman L; Holmgren A; Wedelin B
Acta Anaesthesiol Scand; 1983 Apr; 27(2):142-8. PubMed ID: 6837248
[TBL] [Abstract][Full Text] [Related]
38. Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects.
Eriksson LS; Hagenfeldt L; Mutt V; Wahren J
Peptides; 1989; 10(2):481-4. PubMed ID: 2666962
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
[TBL] [Abstract][Full Text] [Related]
40. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
